Propofol 2% MCT Fresenius
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Propofol 2% MCT Fresenius, covering 2014-02-21 to 2014-02-21. Get the full timeline:
Most recent: Clinical Trial Update: Therapeutic Equivalence (TE) Study of Propofol 2% MCT Fresenius (MCT=Medium-Chain Triglycerides) Compared With Diprivan® in Patients Undergoing Elective Surgery [Phase 3]